Evidence map›Paper›PMID 40177198›Full record

ArticleWorld journal of hepatology2025

Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions.

Arunkumar Krishnan, Diptasree Mukherjee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arunkumar KrishnanDepartment of Supportive Oncology, Atrium Health Levine Cancer, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com.
Diptasree MukherjeeDepartment of Medicine, Apex Institute of Medical Science, Kolkata 700075, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic-associated fatty liver disease (MAFLD), formerly known as nonalcoholic fatty liver disease, is an increasing global health challenge with substantial implications for metabolic and cardiovascular health (CVH). A recent study by Fu

Indexed as

Cardiovascular diseasesCardiovascular healthLife’s Essential 8Life’s Simple 7Lifestyle interventionsMetabolic-associated fatty liver diseaseMultiomicNon-alcoholic fatty liver disease

Identifiers

PMID40177198
PMCPMC11959666

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.